U.S. Stock News

Zentalis Pharmaceuticals (ZNTL) has drawn fresh investor attention after selecting a 400mg once daily, 5-days-on, 2-days-off azenosertib regimen as the optimal monotherapy dose in platinum resistant ovarian cancer. See our latest analysis for Zentalis Pharmaceuticals. The azenosertib update has arrived alongside intense trading interest, with a 1 day share price return of 49.55% and a year to date share price return of 382.48%. The 1 year total shareholder return sits at 437.40%, but the 3...

Ausbil Investment Management has disclosed H2O America (NasdaqGS:HTO) as its largest portfolio holding. ATLAS Infrastructure Partners has reported owning more than 10% of H2O America. These institutional ownership changes highlight a shift in H2O America's shareholder base that has not been widely discussed. For you as an investor, concentrated positions like Ausbil’s and a stake of more than 10% from ATLAS Infrastructure Partners can change how H2O America is viewed in the market. Large,...

U.S. Representative Gilbert Ray Cisneros, Jr. recently disclosed a personal purchase of Cathay General Bancorp (NasdaqGS:CATY) shares. The transaction adds a new political figure to the shareholder base of Cathay General Bancorp, which has previously drawn attention for executive insider activity. The purchase comes with Cathay General Bancorp shares trading around $53.47. Cathay General Bancorp, trading under NasdaqGS:CATY, has seen its shares at about $53.47, with recent returns of 5.7%...

IMAX (NYSE:IMAX) announced that CEO Richard Gelfond has taken a temporary medical leave of absence. The company has described the move as temporary, with existing leadership expected to oversee operations during his absence. IMAX runs a global network of premium large format cinemas and technology partnerships, placing it at the center of the theatrical side of the film industry. The company is closely tied to major studio release schedules and audience demand for big screen experiences...

Lotus Technology Inc. has reported its fourth-quarter and full-year 2025 results, with revenue falling to US$163.34 million for the quarter and US$519.10 million for the year, while net losses narrowed to US$85.77 million and US$464.22 million respectively compared with the prior year. Against this backdrop of shrinking sales but smaller losses, Lotus has also launched its new “For Me” hyper SUV in Beijing, showcasing its X-Hybrid Architecture and underscoring a push toward high-performance...

We wouldn't blame Box, Inc. ( NYSE:BOX ) shareholders if they were a little worried about the fact that Eliahu...

Neogen has agreed to sell its Genomics business to Zoetis as part of a wider portfolio reshaping. The company has completed the divestiture of its Cleaners and Disinfectants business. Neogen is implementing a major restructuring, including a 10% global headcount reduction. These actions concentrate the business around its core Food Safety segment and streamline operations. For investors watching NasdaqGS:NEOG, these moves come after a mixed share price history. The stock is at $9.42, with a...

Medpace Holdings (NasdaqGS:MEDP) is facing multiple shareholder class action lawsuits tied to alleged false and misleading statements about its book to bill ratio and backlog cancellation rates. Investors claim they suffered losses after company disclosures, with recent insider stock sales by the CEO shortly before negative updates adding to concerns. The litigation focuses on whether management provided overly optimistic projections that did not align with internal business conditions. For...

If you are wondering whether Winmark at around US$444 per share offers good value or if you might be arriving late, this piece lays out the key facts so you can judge the price for yourself. The stock has recently moved 3.2% over the last 7 days, with a 1 year return of 37.5% and 10.6% year to date. The 30 day return sits at a 1.2% decline and the 3 and 5 year returns are 46.1% and 163.2% respectively. Recent attention around Winmark has focused on its position in the Specialty Retail space...

Anbio Biotechnology, NasdaqGM:NNNN, is expanding beyond COVID-19 diagnostics into a broader test portfolio. The company is rolling out new rapid immunoassay and PCR platforms across human health, veterinary, and multi-disease applications. This move reflects a business model shift toward more diversified diagnostic revenues and reduced reliance on legacy COVID-19 products. For you as an investor, this repositioning matters because Anbio Biotechnology is moving from a single product focus...

ASP Isotopes (ASPI) has just put out its FY 2025 numbers, with Q4 revenue of about US$16.7 million and a Q4 basic EPS loss of US$0.76. Trailing twelve month revenue sits at roughly US$23.8 million against a TTM basic EPS loss of US$2.11. The company has seen quarterly revenue move from around US$1.2 million in Q4 FY 2024 to US$16.7 million in Q4 FY 2025, while trailing twelve month revenue shifted from about US$4.1 million to US$23.8 million over the same window. Investors will now be...

Unity Software (NYSE:U) is pivoting its ads business toward AI, positioning the Vector ad platform as its primary growth driver. The company is sunsetting the legacy ironSource Ads Network and is exploring a sale of its Supersonic publishing unit. Management expects Vector to reach a billion dollar annual run rate, with recent trends supporting upgrades to company guidance. Unity Software enters this shift with a share price of $21.62 and a mixed return profile, including a 51.1% decline...

Adlai Nortye (NasdaqGM:ANL) has posted its FY 2025 first half results with total revenue of effectively US$0, a basic EPS loss of US$0.57 and net income loss of US$18.34 million, keeping the story firmly about cash burn and margins rather than top line scale. The company has seen recent periods marked by similarly low reported revenue, with basic EPS losses of US$0.64 and US$1.06 and net income losses of US$24.26 million and US$27.61 million across the two halves of FY 2024. As a result,...

We feel now is a pretty good time to analyse QuickLogic Corporation's ( NASDAQ:QUIK ) business as it appears the...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Some Whitehawk Therapeutics, Inc. ( NASDAQ:WHWK ) shareholders may be a little concerned to see that the President...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

In April 2026, Flowco Holdings Inc. filed a shelf registration to offer 1,454,849 shares of Class A common stock, totaling about US$29.97 million, in connection with an ESOP-related transaction. This ESOP-focused shelf registration highlights a potential shift in Flowco’s capital structure and underscores the company’s emphasis on broadening employee ownership. We’ll now examine how this ESOP-related shelf registration might reshape Flowco’s investment narrative, particularly around capital...

Zentalis Pharmaceuticals recently reported that a 400mg once-daily, 5-days-on/2-days-off regimen of azenosertib was selected as the optimal monotherapy dose for Cyclin E1-positive platinum-resistant ovarian cancer, following a prespecified interim analysis from the DENALI Part 2a Phase 2 trial. This dose decision, supported by a differentiated response rate, comparable safety and plans for inclusion in both the pivotal DENALI Phase 2 and confirmatory ASPENOVA Phase 3 trials, is central to...

Wondering whether Biglari Holdings at around US$1,748.76 a share still offers value or if most of the opportunity is already priced in? This article breaks down what the current price might be implying. The stock has had a mixed run recently, with a 1.8% pullback over the last 7 days and a 3.0% gain over the past month, alongside a 3.7% year to date decline and a 71.8% return over the past year. Recent coverage around Biglari Holdings has focused on how its share price performance stacks up...

If you are wondering whether SmartStop Self Storage REIT is priced attractively today, the key question is how its current share price compares with a fair value estimate. The stock last closed at US$31.98, with returns of 3.5% over the past week, 0.1% over the past month, 4.0% year to date and 3.6% over the last year, which may have influenced how the market views its potential and risk. Recent attention on the self storage space has kept SmartStop Self Storage REIT on the radar for...

A prominent institutional fund has fully exited its position in Westinghouse Air Brake Technologies (NYSE:WAB), closing its stake recently. The fund cited concerns that potential consolidation among Class 1 railroads could affect Wabtec’s core freight operations and future profitability. This move draws attention to how a smaller group of large customers might influence pricing, contract terms, and order patterns for freight equipment and services. Westinghouse Air Brake Technologies,...

Lotus Technology (NasdaqGS:LOT) has just posted its FY 2025 third quarter numbers, with revenue of US$137.4 million, a net loss of US$65.4 million and basic EPS of a US$0.10 loss. The trailing twelve months show revenue of US$627.3 million and a net loss of US$818.3 million, or EPS of a US$1.24 loss. Over recent quarters the company has reported revenue moving from US$271.5 million in FY 2024 Q4 to US$92.8 million in FY 2025 Q1, then to US$125.5 million in Q2 and US$137.4 million in Q3...

Simulations Plus (SLP) has put up a mixed Q2 2026 scorecard, with revenue of about US$24.3 million and basic EPS of roughly US$0.22, alongside trailing twelve month figures that show total revenue of about US$80.5 million and a basic EPS loss of roughly US$3.12. Over recent quarters, revenue has ranged from about US$17.5 million to US$24.3 million while quarterly basic EPS has swung between a loss of about US$3.35 and a profit of roughly US$0.22. This leaves investors focused squarely on how...